Oral administration of highly stable, non-absorbed inhibitor aptamer will:
Provide a local effect on GI mucosa
With a very patient-friendly dosing regimen…
While avoiding systemic immunosuppression and thrombosis-related risks
Incubated in simulated gastric fluids
Assayed for full-length, intact, aptamer
Virtually 100% preserved for full duration of incubation
Fully 2’OMethyl aptamer assayed in mass balance study
POC with naked VWF aptamer (BT100) and VWF aptamer w/40KDa PEG (BT200)
HPLC-FL method used for full-length, intact aptamer detection with high sensitivity
~20% total naked aptamer dose recovered in feces
Fecal concentration is 50,000-fold higher than plasma Cmax
Fecal recovery is probably underestimated, as the fecal extraction method has not yet been optimized
~40% total PEGylated aptamer dose recovered in feces
Zero detected in plasma
© 2022 Guardian Therapeutics. All rights reserved.
Headquarters
Guardian Therapeutics
101 Hartwell Avenue
Suite 2
Lexington, MA 02421
+1 (781) 918-6580
General Inquiries:
info@guardian-rx.com
Business Development Inquiries: businessdevelopment@guardian-rx.com